BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2157339)

  • 1. The prevention of congestive heart failure: left ventricular dilation and its management.
    Firth BG; Dunnmon PM
    Am J Med Sci; 1990 Apr; 299(4):276-90. PubMed ID: 2157339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular dilatation and failure post-myocardial infarction: pathophysiology and possible pharmacologic interventions.
    Firth BG; Dunnmon PM
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1363-74. PubMed ID: 2149059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive ventricular dilation in experimental myocardial infarction and its attenuation by angiotensin-converting enzyme inhibition.
    Pfeffer JM
    Am J Cardiol; 1991 Nov; 68(14):17D-25D. PubMed ID: 1836094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement.
    Erlebacher JA; Weiss JL; Weisfeldt ML; Bulkley BH
    J Am Coll Cardiol; 1984 Aug; 4(2):201-8. PubMed ID: 6234343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials.
    Young JB
    Eur Heart J; 1993 Jul; 14 Suppl C():14-7. PubMed ID: 8365422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
    Pfeffer MA; Braunwald E
    Circulation; 1990 Apr; 81(4):1161-72. PubMed ID: 2138525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system in left ventricular remodeling.
    Blaufarb IS; Sonnenblick EH
    Am J Cardiol; 1996 May; 77(13):8C-16C. PubMed ID: 8638527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular enlargement following infarction is a modifiable process.
    Pfeffer MA; Braunwald E
    Am J Cardiol; 1991 Nov; 68(14):127D-131D. PubMed ID: 1836093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular remodeling after myocardial infarction: does the cardiac renin-angiotensin system play a role?
    Lindpaintner K; Niedermaier N; Drexler H; Ganten D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S41-7. PubMed ID: 1380618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of ventricular remodeling after myocardial infarction.
    Anversa P; Olivetti G; Capasso JM
    Am J Cardiol; 1991 Nov; 68(14):7D-16D. PubMed ID: 1836099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Remodeling of the left ventricle after myocardial infarction].
    Droździak E; Piwowarska W
    Pol Merkur Lekarski; 1996 Oct; 1(4):219-22. PubMed ID: 9156927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular remodeling after acute myocardial infarction: clinical course and beneficial effects of angiotensin-converting enzyme inhibition.
    Lamas GA; Pfeffer MA
    Am Heart J; 1991 Apr; 121(4 Pt 1):1194-202. PubMed ID: 1826184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular remodelling after acute myocardial infarction--solved and unsolved issues.
    Bassand JP
    Eur Heart J; 1995 Aug; 16 Suppl I():58-63. PubMed ID: 8829958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventricular remodeling after myocardial infarction. Experimental and clinical studies.
    Ertl G; Gaudron P; Hu K
    Basic Res Cardiol; 1993; 88 Suppl 1():125-37. PubMed ID: 8357328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition limits dysfunction in adjacent noninfarcted regions during left ventricular remodeling.
    Kramer CM; Ferrari VA; Rogers WJ; Theobald TM; Nance ML; Axel L; Reichek N
    J Am Coll Cardiol; 1996 Jan; 27(1):211-7. PubMed ID: 8522697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Physiopathology of left ventricular remodeling after myocardial infarction].
    Bassand JP; Anguenot T
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():43-9. PubMed ID: 1838920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospectives for angiotensin converting enzyme inhibition in heart diseases.
    Tarazi RC; Zanchetti A
    J Hypertens Suppl; 1985 Nov; 3(2):S99-103. PubMed ID: 3003306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of ventricular remodelling post myocardial infarction: timing and duration of therapy.
    Jugdutt BI
    Can J Cardiol; 1993; 9(1):103-14. PubMed ID: 8439824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infarction expansion and ventricular remodelling after acute myocardial infarction].
    Høst NB; Hansen PR
    Ugeskr Laeger; 1993 Oct; 155(43):3463-7. PubMed ID: 8256336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.